Zimmer Biomet Holdings Inc - Company Profile
Powered by 
All the sales intelligence you need on Zimmer Biomet Holdings Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Zimmer Biomet Holdings Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Zimmer Biomet Holdings Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Zimmer Biomet Holdings Inc (Zimmer Biomet) is a medical device company that focuses on musculoskeletal healthcare. The company designs, manufactures and markets orthopedic reconstructive products; suite of integrated digital and robotic technologies; craniomaxillofacial and thoracic products; biologics, sports medicine, extremities, and trauma products; office-based technologies; and associated surgical products. Its products and solutions assist in treating patients suffering from disorders or injuries of bones, joints, and supporting soft tissues. Zimmer Biomet offers products to orthopedic surgeons, stocking distributors, hospitals, healthcare dealers, neurosurgeons, other specialists, and healthcare purchasing organizations. The company markets its products through direct sales channels and distributors in Europe, Asia-Pacific, the Americas, the Middle East and Africa. Zimmer Biomet is headquartered in Warsaw, Indiana, the US.
Headquarters
United States of America
Address
345 E Main St, Warsaw, Indiana, 46580-2746
Website
www.zimmerbiomet.com
Telephone
1 574 2676131
No of Employees
17,000
Industry
Medical Equipment
Ticker Symbol & Exchange
ZBH (NYSE)
Revenue (2024)
$8.2B
3.8%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-11.7%
(2024 vs 2023)
Market Cap*
$16.9B
Net Profit Margin (2023)
XYZ
-15.0%
(2024 vs 2023)
* As of and is in US$
Zimmer Biomet Holdings Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Hip Replacement | Solutions: | Arcos |
| Taperloc Hip System | Artificial Intelligence Solutions | Avenir Complete |
| Zimmer M/l Taper Hip Prosthesis | Infection Solutions | A.L.P.S |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In June, the company entered into an agreement to acquire iovera business from Pacira BioSciences, Inc. |
| 2026 | Contracts/Agreements | In January, the company and PatientIQ entered a strategic collaboration to integrate intra-operative, mobility and patient-reported outcomes data into EHRs. |
| 2025 | Contracts/Agreements | In December, the company and OneStep entered into a partnership to integrate OneStep's gait and mobility analytics into Zimmer Biomet's mymobility Care Management Platform. |
Competitor Comparison
| Key Parameters | Zimmer Biomet Holdings Inc | Medtronic Plc | Stryker Corp | DePuy Synthes Inc | Smith & Nephew Plc |
|---|---|---|---|---|---|
| Headquarters | United States of America | Ireland | United States of America | United States of America | United Kingdom |
| City | Warsaw | Dublin | Portage | Warsaw | Watford |
| State/Province | Indiana | - | Michigan | Indiana | England |
| No. of Employees | 17,000 | 95,000 | 56,000 | - | 16,988 |
| Entity Type | Public | Public | Public | Private | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Ivan Tornos | Chief Executive Officer; President; Chairman | Executive Board | 2025 | 50 |
| Paul Stellato | Controller; Vice President; Chief Accounting Officer; Interim Chief Financial Officer | Senior Management | 2026 | 51 |
| Kristen Cardillo | Chief Communications Officer; Senior Vice President | Senior Management | 2025 | - |
| Angela Main | Senior Vice President; Chief Compliance Officer; Associate General Counsel-Asia Pacific | Senior Management | 2015 | - |
| Chad Phipps | Chief Legal and Corporate Affairs Officer; Senior Vice President; Secretary | Senior Management | 2026 | 54 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer